Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Seriously, I am really perplexed!

OK, I think serveral factors are worth to metion:

1.) Masterplan

IMO PTSC doesn't has a real masterplan how to proceed with the company in the future. And even if we have such a plan, Jim would have some troubles to work with as he isn't able to calculate the amount of money and when it will come in. Both depend on the MMP and furhetmore on the TX decisions. What I mean: PTSC currently cannot plan to do the action xx at the time xx with an amount of money xx as they don't know there revenues......."Big" investors don't like companies wihtout a real business plan.

2. TPL/Masteragreement

PTSC is a public ownded company compared to the private TPL Inc. Both interests differ a lot. IMO, PTSC is currently just a "puppet" controlled by the actions of TPL as they are doing the work and more or less controll the MMP income. One important missing "PR-point" for PTSC e.g. is the amount of money per deal which the masteragreement dissalows . We even allowed to get an idea or a category....."Big" investors like independend companies doing business without a "controlling" partner like TPL.

3. TX an USPTO

Both points are risc factors for potential investors as a negavtiv outcome in TX leads to enormous problems for PTSC. They don't have a second revenue stream establised and the current bank depposite doens't allow big actions to do so. USPTO could delay the time shedule if they have to rework some claims etc............

Best wishes

S402005

Share
New Message
Please login to post a reply